Buy & Sell Novo Nordisk A/S (NVO) – Novo Nordisk A/S Price Today
Aura AI Summary
Key Stats
- $183.02BMarket Cap
- HealthSector
- -40.62%3M Drawdown
- $199.31BEnterprise Value
- 4.37%Dividend Yield
- 92% Buy | 8% SellTrading Activity
- 99 daysTypical Hold Time
Novo Nordisk A/S (NVO) is currently valued at a market capitalization of $183.02B, with an enterprise value of $199.31B. Over the past 52 weeks, Novo Nordisk A/S has traded between a low of $35.29 and a high of $81.05, highlighting its annual price range. Over the past three months, Novo Nordisk A/S has recorded a drawdown of -40.62%, reflecting recent price volatility. Novo Nordisk A/S offers a dividend yield of 4.37%, with the most recent dividend of $1.28 paid on 30 Mar 26. On average, investors hold Novo Nordisk A/S for approximately 99 days, indicating typical investor behavior on the platform.
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
